Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 52
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Saving the most endangered seabird in the Americas

Seven years of intense field monitoring and automated recordings, showed us which factors negatively impact...

A non-invasive way to track the fluffy yellow-bellied gliders of North Queensland, Australia

The Yellow-bellied glider (YBG) is a unique animal that glides between trees of woodlands in North-eastern...

Backer Badge Funded